Healthcare -
Biotechnology - NASDAQ - US
$ 8.885
-1.39 %
$ 1.42 B
Market Cap
-4.08
P/E
NVAX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities NVAX - Novavax, Inc.
4.47 M
LAST VALUE
-90.17%
2 YEAR CAGR
-46.60%
5 YEAR CAGR
-28.67%
10 YEAR CAGR